{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:14:48Z","timestamp":1788178488916,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,2]]},"DOI":"10.7759\/cureus.106323","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T14:03:17Z","timestamp":1775138597000},"source":"Crossref","is-referenced-by-count":1,"title":["Biomarkers in the Early Detection of Dementia: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Emma","family":"Putnam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Katsoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond L","family":"Ownby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc M","family":"Kesselman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425787","article-title":"","year":"2013","unstructured":"Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association, 2013. 10.1176\/appi.books.9780890425787"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.4782","article-title":"Diagnosis and management of dementia: review","volume":"322","author":"Arvanitakis Z","year":"2019","unstructured":"Arvanitakis Z, Shah RC, Bennett DA. Diagnosis and management of dementia: review. JAMA. 2019, 322:1589-99. 10.1001\/jama.2019.4782","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1117\/1.NPh.9.4.045010","article-title":"Early screening model for mild cognitive impairment based on resting-state functional connectivity: a functional near-infrared spectroscopy study","volume":"9","author":"Zhang S","year":"2022","unstructured":"Zhang S, Zhu T, Tian Y, Jiang W, Li D, Wang D. Early screening model for mild cognitive impairment based on resting-state functional connectivity: a functional near-infrared spectroscopy study. Neurophotonics. 2022, 9:045010. 10.1117\/1.NPh.9.4.045010","journal-title":"Neurophotonics"},{"key":"ref4","article-title":"Cognitive impairment in older adults: epidemiology, diagnosis, and treatment","volume":"54","author":"Palmer NP","year":"2022","unstructured":"Palmer NP, Ortega BT, Joshi P. Cognitive impairment in older adults: epidemiology, diagnosis, and treatment. Psychiatr Clin North Am. 2022, 54:639-61.","journal-title":"Psychiatr Clin North Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000001133","article-title":"The value of neuroimaging in dementia diagnosis","volume":"28","author":"Raji CA","year":"2022","unstructured":"Raji CA, Benzinger TL. The value of neuroimaging in dementia diagnosis. Continuum (Minneap Minn). 2022, 28:800-21. 10.1212\/CON.0000000000001133","journal-title":"Continuum (Minneap Minn)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/bios15030151","article-title":"Recent advances in electrochemical biosensors for neurodegenerative disease biomarkers","volume":"15","author":"Bae M","year":"2025","unstructured":"Bae M, Kim N, Cho E, Lee T, Lee JH. Recent advances in electrochemical biosensors for neurodegenerative disease biomarkers. Biosensors (Basel). 2025, 15:151. 10.3390\/bios15030151","journal-title":"Biosensors (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/1533317518791401","article-title":"Mild cognitive impairment in clinical practice: a review article","volume":"33","author":"Jongsiriyanyong S","year":"2018","unstructured":"Jongsiriyanyong S, Limpawattana P. Mild cognitive impairment in clinical practice: a review article. Am J Alzheimers Dis Other Demen. 2018, 33:500-7. 10.1177\/1533317518791401","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01382-x","article-title":"Biomarkers for neurodegenerative diseases","volume":"27","author":"Hansson O","year":"2021","unstructured":"Hansson O. Biomarkers for neurodegenerative diseases. Nat Med. 2021, 27:954-63. 10.1038\/s41591-021-01382-x","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.776","article-title":"Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline","volume":"7","author":"Eliassen CF","year":"2017","unstructured":"Eliassen CF, Reinvang I, Selnes P, Grambaite R, Fladby T, Hessen E. Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline. Brain Behav. 2017, 7:e00776. 10.1002\/brb3.776","journal-title":"Brain Behav"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112841","article-title":"Phosphorylated Tau in Alzheimer\u2019s disease and other Tauopathies","volume":"23","author":"Rawat P","year":"2022","unstructured":"Rawat P, Sehar U, Bisht J, Selman A, Culberson J, Reddy PH. Phosphorylated Tau in Alzheimer\u2019s disease and other Tauopathies. Int J Mol Sci. 2022, 23:10.3390\/ijms232112841","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115522","article-title":"Alzheimer's disease: insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs","volume":"211","author":"Monteiro AR","year":"2023","unstructured":"Monteiro AR, Barbosa DJ, Remi\u00e3o F, Silva R. Alzheimer's disease: insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs. Biochem Pharmacol. 2023, 211:115522. 10.1016\/j.bcp.2023.115522","journal-title":"Biochem Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094610","article-title":"Molecular biomarkers and their implications for the early diagnosis of selected neurodegenerative diseases","volume":"23","author":"Doroszkiewicz J","year":"2022","unstructured":"Doroszkiewicz J, Groblewska M, Mroczko B. Molecular biomarkers and their implications for the early diagnosis of selected neurodegenerative diseases. Int J Mol Sci. 2022, 23:4610. 10.3390\/ijms23094610","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.70111","article-title":"Comparative diagnostic performance of amyloid\u2010\u03b2 positron emission tomography and magnetic resonance imaging in alzheimer\u2019s disease: a head\u2010to\u2010head meta\u2010analysis","volume":"14","author":"Li F","year":"2024","unstructured":"Li F, Cheng J, Jin K, Zhao L, Li J, Wu J, Ren X. Comparative diagnostic performance of amyloid\u2010\u03b2 positron emission tomography and magnetic resonance imaging in alzheimer\u2019s disease: a head\u2010to\u2010head meta\u2010analysis. Brain Behav. 2024, 14:e70111. 10.1002\/brb3.70111","journal-title":"Brain Behav"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1468246","article-title":"An exploration of distinguishing subjective cognitive decline and mild cognitive impairment based on resting-state prefrontal functional connectivity assessed by functional near-infrared spectroscopy","volume":"16","author":"Pu Z","year":"2024","unstructured":"Pu Z, Huang H, Li M, et al.. An exploration of distinguishing subjective cognitive decline and mild cognitive impairment based on resting-state prefrontal functional connectivity assessed by functional near-infrared spectroscopy. Front Aging Neurosci. 2024, 16:1468246. 10.3389\/fnagi.2024.1468246","journal-title":"Front Aging Neurosci"},{"key":"ref15","unstructured":"CASP checklist. For systematic reviews. (2025). Accessed: December 17, 2025: http:\/\/uk.net\/casp-checklists\/CASP-checklist-systematic-reviews-checklist-2024.pdf."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2011.155","article-title":"Cerebrospinal fluid levels of \u03b2-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia","volume":"69","author":"Buchhave P","year":"2012","unstructured":"Buchhave P, Minthon L, Zetterberg H, Wallin AK, Blennow K, Hansson O. Cerebrospinal fluid levels of \u03b2-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Arch Gen Psychiatry. 2012, 69:98-106. 10.1001\/archgenpsychiatry.2011.155","journal-title":"Arch Gen Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30028-0","article-title":"Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study","volume":"17","author":"Gordon BA","year":"2018","unstructured":"Gordon BA, Blazey TM, Su Y, et al.. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study. Lancet Neurol. 2018, 17:241-50. 10.1016\/S1474-4422(18)30028-0","journal-title":"Lancet Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A3644","article-title":"An expanded role for neuroimaging in the evaluation of memory impairment","volume":"34","author":"Desikan RS","year":"2013","unstructured":"Desikan RS, Rafii MS, Brewer JB, Hess CP. An expanded role for neuroimaging in the evaluation of memory impairment. AJNR Am J Neuroradiol. 2013, 34:2075-82. 10.3174\/ajnr.A3644","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-9016-3","article-title":"Magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment","volume":"266","author":"Chandra A","year":"2019","unstructured":"Chandra A, Dervenoulas G, Politis M. Magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment. J Neurol. 2019, 266:1293-302. 10.1007\/s00415-018-9016-3","journal-title":"J Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/457210-biomarkers-in-the-early-detection-of-dementia-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T14:03:18Z","timestamp":1775138598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/457210-biomarkers-in-the-early-detection-of-dementia-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.106323","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,2]]}}}